VOV.VN - The Ministry of Health has recently granted approval for clinical trials to begin on the ARCT-154 COVID-19 vaccine, with medical tests set to begin on August 8 at Hanoi Medical University.

VOV.VN - Vingroup, a leading multi-sectoral conglomerate in Vietnam, has reached a deal with its partner to purchase 500,000 vials of Remdesivir, an antiviral drug licensed by the US Food and Drug Administration, for COVID-19 treatment in Vietnam.

VOV.VN - Vingroup, a leading Vietnamese multi-sectoral conglomerate, plans to build a COVID-19 vaccine production plant in Hanoi with a designed capacity of between 100-200 million doses a year.

VOV.VN - Vingroup, Vietnam’s largest conglomerate, unveiled on July 27 that it has appointed Michael Lohscheller, former vice president of Volkswagen USA and Opel CEO, as the latest CEO of its automotive division VinFast Global.

VOV.VN - A group featuring 105 collectives, businesses, and individuals in Ho Chi Minh City have registered to contribute more than VND2,293 billion in support of the purchase of COVID-19 vaccines and medical equipment in the southern city’s ongoing battle against the virus.

“DrAid for Radiology” by VinBrain -a subsidiary of Vingroup in Vietnam- has just been granted the ACM SIGAI Industry Award 2021 for Excellence in Artificial Intelligence.

Despite the impact of the COVID-19 pandemic, Vietnamese auto-maker VinFast Trading and Production LLC still enjoyed a month-on-month increase of 5% in sales in May, to 2,855 vehicles.

Vinhomes Smart City, an urban complex developed by VinGroup’s Vinhomes in Hanoi, has won the Mixed Use Development and Sustainable Residential Development categories at the 2021 Asia Pacific Property Awards (APPA).

VOV.VN - Vietnamese conglomerate Vingroup handed over novel coronavirus (COVID-19) breath testing system on June 4 worth over VND460 billion, equal to US$20 million, to the Ministry of Health (MoH) as part of efforts to defeat the ongoing pandemic.

VOV.VN - The Ministry of Health (MoH) has received VND160 billion in donations from various local banks as funding for the purchase of additional novel coronavirus (COVID-19) vaccine doses.